What Researchers Did
Researchers investigated whether adding intratympanic steroid (ITS) to systemic steroid and hyperbaric oxygen (HBO) improved outcomes for 58 patients with sudden hearing loss (SHL).
What They Found
Overall treatment success was 55% in patients receiving systemic steroid and HBO, compared to 63% in those also receiving ITS, though this difference was not statistically significant (p>0.05). However, for patients with profound hearing loss over 90 dB, ITS significantly improved success from 0% (0 of 6 patients) to 50% (6 of 12 patients) (p<0.05).
What This Means for Canadian Patients
Canadian patients experiencing sudden hearing loss, particularly profound cases, might benefit from the addition of intratympanic steroid injections to standard systemic steroid and hyperbaric oxygen therapy. This combined approach could offer a better chance of hearing recovery for severe hearing loss.
Canadian Relevance
This study has no direct Canadian connection or specific Canadian relevance mentioned.
Study Limitations
The study's relatively small sample size and single-center design limit the generalizability of its findings.